UnitedHealth Group (UNH) Soars 5.77% on Medicare Payout Boost

On April 8, 2025, UnitedHealth Group's stock surged by 5.77% in pre-market trading, reflecting a significant upward momentum.

UnitedHealth Group's stock price has been influenced by several key factors. The Trump administration's decision to significantly increase the payout rate for Medicare insurers next year is expected to bring over $25 billion in additional revenue to the industry. This move is anticipated to double the increase proposed in January, providing a substantial boost to UnitedHealth Group's financial outlook.

Additionally, UnitedHealth Group is expected to release its earnings report on April 17, 2025. Analysts project earnings per share (EPS) of $7.27, representing a 5.21% increase from the prior-year quarter. Revenue is estimated to reach $111.01 billion, up 11.24% from the previous year. For the full year, the consensus estimates project earnings of $29.73 per share and revenue of $451.2 billion, demonstrating changes of +7.48% and +12.72%, respectively, from the preceding year.

Investors are also closely monitoring recent changes to analyst estimates for UnitedHealth Group. Positive revisions in estimates typically reflect analysts' confidence in the company's business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. UnitedHealth Group is currently rated as a Zacks Rank #2 (Buy), indicating a favorable outlook for the stock.